Compare HP Inc (HPQ) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HP Inc vs ResMed Inc. — how do they compare? HP Inc trades at $30.2 (market cap $29.25B), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: HP Inc and ResMed Inc. are close in size by market cap, and HP Inc pays the higher dividend (3.7%). Which is the better fit depends on your goals — on Pluang, investors hold HP Inc for 69 Days and ResMed Inc. for 51 Days on average.
| HPQ | RMD | |
|---|---|---|
Market Cap | $29.25B | $31.89B |
Volume | 10,025,806 | 618,314 |
Sector | Technology | Health |
52-Week High | $35.48 | $275.96 |
52-Week Low | $18.20 | $182.82 |
Typical Hold Time | 69 Days | 51 Days |
Enterprise Value | $35.42B | $31.24B |
Dividend Yield | 3.7% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPQ trades at $32.44, up 0.62% today, with a bullish technical signal from moving averages. The stock has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue is projected to grow to $59.2B in 2026, though net margins are compressing. Recent news highlights HP's new AI-ready PCs but also a cautious outlook for 2027 PC sales.
The outlook is mixed: valuation appears reasonable with a P/E of 12.38, but declining PC demand poses a headwind. Analyst consensus is cautious with a hold-heavy rating, though the stock offers a 3.82% dividend yield. Key risks include execution in a competitive hardware market and macroeconomic sensitivity.
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
